Ambisense Ltd.

Ambisense Ltd.

Ambisense Ltd.


DCU Innovation Campus,Rodgers Building,Glasnevin, Dublin 9

Type of Company



Electrical Products
IT Consulting & Services
Holding Companies

Company Description

Ambisense Ltd. designs and manufacturers smart, field deployable, gas monitoring instruments and networks. It provides a continuous flow of data, accessible to customers on any device. The company was founded by Stephen Mcnulty, Fiachra Collins and Dermot Diamond and is headquartered in Glasnevin, Ireland.

Executives & Employees

Scientific Advisor

Board of Directors

President, Chief Executive Officer, Director at Falcon Oil & Gas Ltd.

Managing Director at Oxymem Ltd.

Paths to Ambisense Ltd.
Potential Connections via
Relationship Science
Ambisense Ltd.
Details Hidden

Atlantic Bridge's investment objective is to seek superior financial returns. Their investment strategy focuses on early- and mid-stage transactions in European firms with strong core technology. Other core investment criteria include firms with growth potential to become leaders in their targeted areas within large markets, experienced management team within sector, robust business model, early customer validation displaying clear benefits, obvious channels to market, capability for building prominent global market position and long-term financial returns on investment.Within the technology sector, Atlantic Bridge specifically targets firms in the following areas: semiconductors, semiconductor process technologies and capital equipment, enterprise and mobile communication software, communications equipment, telecommunications network management software and Internet infrastructure and services. Atlantic Bridge's main geographic focus is initially Western Europe and also beyond. They are experienced with investments in Ireland, France, Germany, Switzerland, the Netherlands, Denmark, Finland, Norway, Sweden, Italy, Spain, the UK as well as the US.Atlantic Bridge typically invests between $1 million and $5 million contingent on the development stage and firm's sector. They seek to build significant holdings in their portfolio firms over multiple investment rounds. They are long-term investors and maintain their holding through to a successful exit. Over the investment lifetime, they generally invest from $3 million to $10 million.Atlantic Bridge also utilizes the Transatlantic Model investment approach. This strategy targets the US as the second business market in which European venture-backed firms are scaled. To achieve market scale, they believe that greater shareholder value is obtained by going from a European country to the US as opposed to seeking growth opportunities across Europe. The model also aspires for an IPO on NASDAQ. Whether this materializes or not, Atlantic Bridge maintains this significantly enhances shareholder value. The firm also aims to develop syndicate transactions with other venture capitalists employing the Transatlantic Model in Europe.

Details Hidden

EI's primary strategic focus for Irish firms is on five areas of activity: achieving export sales; investing in research and innovation; competing through productivity; starting up and scaling up and driving regional enterprise. EI's main objective is assisting company growth and they recognize the role of innovation as a key enabler.EI's International Traded Services Division concentrates further on the development of scaled Irish firms, targeting four key sectors: financial and business process outsourcing services; new services prospecting telecommunications; internet, media and entertainment; and professional consultancy and other services.Through EI's Seed and Venture Capital Scheme, they aim to further leverage the growth of the venture capital system in Ireland to broaden access for start-up, early stage and development stage businesses.EI's main trading partners are the UK, Europe, Asia and the US. They are also assisting Irish firms to grow their export share in emerging markets such as China, India, Brazil, Japan, Russia and the Gulf States.

Details Hidden

Scientific Advisor at Ambisense Ltd.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Ambisense Ltd.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Ambisense Ltd.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Ambisense Ltd..
  • be_ixf; php_sdk; php_sdk_1.4.15